These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 36889588)

  • 1. Phosphatase regulatory subunit MYPT2 knockout partially compensates for the cardiac dysfunction in mice caused by lack of myosin light chain kinase 3.
    Hu T; Kalyanaraman H; Pilz RB; Casteel DE
    J Biol Chem; 2023 Apr; 299(4):104584. PubMed ID: 36889588
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Overexpression of myosin phosphatase reduces Ca(2+) sensitivity of contraction and impairs cardiac function.
    Mizutani H; Okamoto R; Moriki N; Konishi K; Taniguchi M; Fujita S; Dohi K; Onishi K; Suzuki N; Satoh S; Makino N; Itoh T; Hartshorne DJ; Ito M
    Circ J; 2010 Jan; 74(1):120-8. PubMed ID: 19966500
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Constitutive phosphorylation of cardiac myosin regulatory light chain in vivo.
    Chang AN; Battiprolu PK; Cowley PM; Chen G; Gerard RD; Pinto JR; Hill JA; Baker AJ; Kamm KE; Stull JT
    J Biol Chem; 2015 Apr; 290(17):10703-16. PubMed ID: 25733667
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization and function of MYPT2, a target subunit of myosin phosphatase in heart.
    Okamoto R; Kato T; Mizoguchi A; Takahashi N; Nakakuki T; Mizutani H; Isaka N; Imanaka-Yoshida K; Kaibuchi K; Lu Z; Mabuchi K; Tao T; Hartshorne DJ; Nakano T; Ito M
    Cell Signal; 2006 Sep; 18(9):1408-16. PubMed ID: 16431080
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Functional and Molecular Characterisation of Heart Failure Progression in Mice and the Role of Myosin Regulatory Light Chains in the Recovery of Cardiac Muscle Function.
    Markandran K; Yu H; Song W; Lam DTUH; Madathummal MC; Ferenczi MA
    Int J Mol Sci; 2021 Dec; 23(1):. PubMed ID: 35008512
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Degradation of cardiac myosin light chain kinase by matrix metalloproteinase-2 contributes to myocardial contractile dysfunction during ischemia/reperfusion.
    Gao L; Zheng YJ; Gu SS; Tan JL; Paul C; Wang YG; Yang HT
    J Mol Cell Cardiol; 2014 Dec; 77():102-12. PubMed ID: 25451385
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiac myosin light chain kinase is necessary for myosin regulatory light chain phosphorylation and cardiac performance in vivo.
    Ding P; Huang J; Battiprolu PK; Hill JA; Kamm KE; Stull JT
    J Biol Chem; 2010 Dec; 285(52):40819-29. PubMed ID: 20943660
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Distinct roles of ROCK (Rho-kinase) and MLCK in spatial regulation of MLC phosphorylation for assembly of stress fibers and focal adhesions in 3T3 fibroblasts.
    Totsukawa G; Yamakita Y; Yamashiro S; Hartshorne DJ; Sasaki Y; Matsumura F
    J Cell Biol; 2000 Aug; 150(4):797-806. PubMed ID: 10953004
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overexpression of heart-specific small subunit of myosin light chain phosphatase results in heart failure and conduction disturbance.
    Arimura T; Muchir A; Kuwahara M; Morimoto S; Ishikawa T; Du CK; Zhan DY; Nakao S; Machida N; Tanaka R; Yamane Y; Hayashi T; Kimura A
    Am J Physiol Heart Circ Physiol; 2018 Jun; 314(6):H1192-H1202. PubMed ID: 29451818
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prostanoid F receptors elicit an inotropic effect in rat left ventricle by enhancing myosin light chain phosphorylation.
    Riise J; Nguyen CH; Qvigstad E; Sandnes DL; Osnes JB; Skomedal T; Levy FO; Krobert KA
    Cardiovasc Res; 2008 Dec; 80(3):407-15. PubMed ID: 18703533
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Physiological vs. pharmacological signalling to myosin phosphorylation in airway smooth muscle.
    Gao N; Tsai MH; Chang AN; He W; Chen CP; Zhu M; Kamm KE; Stull JT
    J Physiol; 2017 Oct; 595(19):6231-6247. PubMed ID: 28749013
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Agonist- and depolarization-induced signals for myosin light chain phosphorylation and force generation of cultured vascular smooth muscle cells.
    Woodsome TP; Polzin A; Kitazawa K; Eto M; Kitazawa T
    J Cell Sci; 2006 May; 119(Pt 9):1769-80. PubMed ID: 16608882
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Physiological signalling to myosin phosphatase targeting subunit-1 phosphorylation in ileal smooth muscle.
    Gao N; Chang AN; He W; Chen CP; Qiao YN; Zhu M; Kamm KE; Stull JT
    J Physiol; 2016 Jun; 594(12):3209-25. PubMed ID: 26847850
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The significance of regulatory light chain phosphorylation in cardiac physiology.
    Scruggs SB; Solaro RJ
    Arch Biochem Biophys; 2011 Jun; 510(2):129-34. PubMed ID: 21345328
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Myosin light chain phosphatase catalytic subunit dephosphorylates cardiac myosin via mechanisms dependent and independent of the MYPT regulatory subunits.
    Lee E; Liu Z; Nguyen N; Nairn AC; Chang AN
    J Biol Chem; 2022 Sep; 298(9):102296. PubMed ID: 35872014
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functions of myosin light chain-2 (MYL2) in cardiac muscle and disease.
    Sheikh F; Lyon RC; Chen J
    Gene; 2015 Sep; 569(1):14-20. PubMed ID: 26074085
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Myosin regulatory light chain phosphorylation attenuates cardiac hypertrophy.
    Huang J; Shelton JM; Richardson JA; Kamm KE; Stull JT
    J Biol Chem; 2008 Jul; 283(28):19748-56. PubMed ID: 18474588
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Decreased myosin phosphatase target subunit 1(MYPT1) phosphorylation via attenuated rho kinase and zipper-interacting kinase activities in edematous intestinal smooth muscle.
    Chu J; Miller CT; Kislitsyna K; Laine GA; Stewart RH; Cox CS; Uray KS
    Neurogastroenterol Motil; 2012 Mar; 24(3):257-66, e109. PubMed ID: 22235829
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The myosin phosphatase targeting protein (MYPT) family: a regulated mechanism for achieving substrate specificity of the catalytic subunit of protein phosphatase type 1δ.
    Grassie ME; Moffat LD; Walsh MP; MacDonald JA
    Arch Biochem Biophys; 2011 Jun; 510(2):147-59. PubMed ID: 21291858
    [TBL] [Abstract][Full Text] [Related]  

  • 20. β-adrenergic activation may promote myosin light chain kinase degradation through calpain in pressure overload-induced cardiac hypertrophy: β-adrenergic activation results in MLCK degradation.
    Wang S; Wang H; Su X; Liu B; Wang L; Yan H; Mao S; Huang H; Huang C; Cheng M; Wu G
    Biomed Pharmacother; 2020 Sep; 129():110438. PubMed ID: 32768940
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.